Key terms
About GSK
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest GSK news
Yesterday
1:58pm ET
GSK Forecasts a Year of Strong Growth
Yesterday
12:35pm ET
GSK Pharma put volume heavy and directionally bearish
Yesterday
12:01pm ET
GSK Updates Share Capital and Voting Rights
Yesterday
6:26am ET
GSK raises 2024 core EPS growth view to 8%-10% from 6%-9%
Yesterday
6:23am ET
GSK reports Q1 core EPS 43.1p, up 28% at CER
Apr 30
11:45am ET
GSK Pharma call volume above normal and directionally bullish
Apr 30
10:13am ET
FTC expands patent listing challenges for drugs
Apr 24
7:57am ET
GSK’s Jemperli Awaits FDA Expansion Approval
Apr 24
7:56am ET
CureVac, GSK terminate Pandemic Preparedness Agreement
Apr 24
7:29am ET
CureVac, GSK announce start of Phase 1 part of investigational H5N1 trial
Apr 24
7:29am ET
CureVac announces start of Phase 1/2 study in avian influenza
Apr 24
6:25am ET
GSK: FDA accepts expanded Jemperli indication application for priority review
Apr 23
8:34am ET
Wave Life Sciences announces continued momentum in GSK collaboration
Apr 19
6:21pm ET
VGK vs. EZU: Which Is the Better European Stock ETF?
Apr 19
11:57am ET
GSK Executives Reinforce Commitment via Share Purchase
Apr 17
11:57am ET
GSK Executives Reinvest Dividends in Shares
Apr 17
10:40am ET
Analysts Offer Insights on Healthcare Companies: Agilent (A), GlaxoSmithKline (GSK) and Stryker (SYK)
Apr 17
7:00am ET
GSK’s Shingrix Vaccine Proves Long-term Efficacy
Apr 17
7:00am ET
GSK’s New Antibiotic Shows High Success Rate
Apr 17
6:14am ET
GSK announces data from the ZOSTER-049 long-term phase III trial of Shingrix
Apr 17
6:13am ET
GSK announces results from its EAGLE-1 phase III trial for gepotidacin
Apr 16
10:27am ET
GSK Corrects Executive Shareholding Disclosure
Apr 16
6:57am ET
GSK’s 5-in-1 Meningococcal Vaccine Under FDA Review
Apr 16
6:21am ET
GSK meningococcal ABCWY vaccine candidate accepted for FDA review
Apr 15
9:04pm ET
GSK Executives Invest in Company’s Future
Apr 08
3:14pm ET
GSK price target raised to 1,725 GBp from 1,575 GBp at Barclays
Apr 08
8:13am ET
ViiV Healthcare announces FDA approval of Dovato for adolescents with HIV
Apr 04
7:23am ET
CureVac announces Phase 2 interim data from influenza vaccine program
Apr 02
1:59pm ET
GSK Updates Total Voting Rights for Shareholders
Mar 26
8:57am ET
GSK Executive Sells Shares on LSE
Mar 22
1:57pm ET
GlaxoSmithKline Executes Major Share Transfer
No recent press releases are available for GSK
GSK Financials
Key terms
Ad Feedback
GSK Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
GSK Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
